Perflubron: Difference between revisions
No edit summary |
No edit summary |
||
Line 51: | Line 51: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
'''Perflubron''' ([[International Nonproprietary Name|INN]]/[[United States Adopted Name|USAN]], or '''perfluorooctyl bromide'''; brand name '''Imagent''') is a [[contrast medium]] for [[magnetic resonance imaging]], [[computer tomography]] and [[sonography]]. | '''Perflubron''' ([[International Nonproprietary Name|INN]]/[[United States Adopted Name|USAN]], or '''perfluorooctyl bromide'''; brand name '''Imagent''') is a [[contrast medium]] for [[magnetic resonance imaging]], [[computer tomography]] and [[sonography]].It was approved for this use in the United States by the [[Food and Drug Administration]] in 1993.<ref> | ||
==Experimental research== | ==Experimental research== | ||
Perflubron has also been tested experimentally for use in [[liquid breathing]] in premature infants with respiratory distress. | Perflubron has also been tested experimentally for use in [[liquid breathing]] in premature infants with respiratory distress. | ||
[[File:Molecular ball-and-stick model of Perflubron, overlayed with electron-denisty coded VdW model.png|none|left|400px]] | [[File:Molecular ball-and-stick model of Perflubron, overlayed with electron-denisty coded VdW model.png|none|left|400px]] |
Revision as of 20:28, 10 April 2015
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C8BrF17 |
Molar mass | 498.96 g/mol |
3D model (JSmol) | |
Density | 1.93 g/cm3 |
Melting point | 6 °C (42.8 °F) |
Boiling point | 142 °C (287.6 °F) |
| |
|
WikiDoc Resources for Perflubron |
Articles |
---|
Most recent articles on Perflubron |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Perflubron at Clinical Trials.gov Clinical Trials on Perflubron at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Perflubron
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Perflubron Discussion groups on Perflubron Patient Handouts on Perflubron Directions to Hospitals Treating Perflubron Risk calculators and risk factors for Perflubron
|
Healthcare Provider Resources |
Causes & Risk Factors for Perflubron |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Perflubron (INN/USAN, or perfluorooctyl bromide; brand name Imagent) is a contrast medium for magnetic resonance imaging, computer tomography and sonography.It was approved for this use in the United States by the Food and Drug Administration in 1993.<ref>
Experimental research
Perflubron has also been tested experimentally for use in liquid breathing in premature infants with respiratory distress.